Atrial flutter ablation with an MRI-guided mapping system
Part of Heart & circulation clinical trials.
This trial studies how well an MRI-guided approach works during atrial flutter ablation. If you’ve had recent atrial flutter episodes, it may help doctors target the heart rhythm problem more precisely and safely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have had type 1 atrial flutter at least once in the last 6 months
- You can safely have an MRI (no MRI-related medical contraindications)
- You have no recent major heart or brain circulation events (like heart attack, stroke/TIA) within the listed time windows
- You can take blood thinners, and you do not have a blood clot or heart mass inside the heart during screening
- You have not had a prior CTI ablation, and you meet limits about recent heart surgery or certain heart valve/patch devices
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether blocking extra heart electrical pathways during atrial flutter ablation surgery can help prevent atrial fibrillation (a more serious heart rhythm problem) from developing later. If you have atrial flutter and are planning ablation surgery, this study may help protect your heart's rhythm long-term.
This study tests a new device that uses focused pulses of energy to treat a common type of fast heartbeat called typical atrial flutter. It aims to see if this approach is safe and effective for people who have had at least one episode in the past 6 months.
This trial studies a catheter procedure that targets areas in the heart that show low electrical voltage to treat atrial fibrillation (an irregular heartbeat). You may be eligible if you have non-paroxysmal atrial fibrillation, have tried heart rhythm medicines, and your scan shows low-voltage areas in the left atrium.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
This trial studies a heart rhythm procedure (“ablation”) for people with ischemic cardiomyopathy who have ongoing episodes of sustained ventricular tachycardia. It aims to reduce these dangerous rhythm events, especially when standard anti-rhythm medications don’t work or can’t be used.
This trial is testing a new way to treat atrial fibrillation by using a catheter to target the specific areas in the heart that trigger the irregular heartbeat. If you have persistent atrial fibrillation and haven't had prior catheter ablation, you may be eligible to join.
Hear when a new Atrial Flutter Typical trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.